27th Mar 2007 13:02
PuriCore Plc27 March 2007 27 March 2007 PuriCore signs additional endoscope reprocessor marketing partnership Sterilox Endoscopy and BHT to offer complete solutions for high capacity endoscope reprocessing in the UK PuriCore (LSE: PURI), the life sciences company focused on the development andcommercialisation of its novel, safe antimicrobial technology, today announcesthat its Sterilox Endoscopy division has established a sales and marketingpartnership with BHT Hygienetechnik GmbH, the Frost and Sullivan award winningmanufacturer of endoscope reprocessors and channel checking systems (INNOVA(R)CC). This new partnership significantly enhances PuriCore's product portfolio. Thecombination of Frost and Sullivan award-winning technologies from SteriloxEndoscopy and BHT will deliver amongst the fastest and safest large pass throughreprocessing systems in the UK. The deal ensures that PuriCore and BHT canrespond to their clients' need for high quality infection control. This joint approach is proving successful, and a number of orders have alreadybeen confirmed and reprocessing systems are due to be installed over the comingmonths. This deal follows last month's announcement that PuriCore had signed anexclusive distribution agreement with Minntech Corporation, one of the world'sleading manufacturers of automated endoscope reprocessors. Greg Bosch, Chief Executive of PuriCore, said: "PuriCore is pleased to announce another partnership with a world-class AERmanufacturer. The integration of our technologies provides significantcost-saving benefits to our NHS customers and further strengthens our positionas the UK's leading provider of endoscopy reprocessing systems". Dr. Annecke, CEO and Managing Director of BHT, said: "The joint effort allows BHT to expand its existing offerings in the UK marketfor high level disinfection solutions in the most sensitive field ofreprocessing flexible endoscopes." Contacts: PuriCore plc +1 (484) 321-2700Greg Bosch, Chief Executive OfficerKeith A. Goldan, Chief Financial Officer FD +44 (0) 20 7831 3113Ben BrewertonJohn Gilbert Notes to Editors: Sterilox Endoscopy is a division of PuriCore. About PuriCore PuriCore (LSE: PURI) is a life sciences company focused on the development andcommercialisation of its proprietary technology that mimics the production bythe human body of its natural anti-microbial, hypochlorous acid. Hypochlorousacid is highly effective at killing pathogens such as bacteria, viruses andfungi and yet is safe and environmentally friendly. PuriCore's solutions haveapplications in a wide range of markets where it is important to controlmicrobial contamination. These markets include medical device disinfection,food safety, dental equipment decontamination, environmental remediation,hospitality, water safety, wound management and other applications intended tolimit the spread of infectious disease, including major global disease threatssuch as Tuberculosis, MRSA, Influenza, E.coli, Norovirus, HIV, polio, HepatitisA, H.pylori and Legionella. PuriCore markets a portfolio of branded systems which produce hypochlorous acidsolutions on-site at a customer's location from water, electricity and commonsalt. These solutions are generated at a range of concentrations and at anearly neutral pH range similar to the human body. They are effective as soaks,sprays, mists and in other forms. PuriCore is headquartered in Malvern, Pennsylvania with offices in Stafford, UK. To receive additional information on PuriCore or its Sterilox Endoscopydivision, please visit our web site at www.puricore.com, which does not formpart of this press release. About BHT BHT is one of the acknowledged market leaders in the design and manufacturing ofinnovative washers and disinfectors for the medical, dental, laboratory andpharmaceutical market for more than 25 years. BHT distributes products andservice to domestic and international clients from its world wide headquarter inGersthofen near Augsburg, Germany. The company has been awarded in 2005 with theFrost & Sullivan Product Innovation Award, Healthcare for its INNOVA CC product.BHT is certified according DIN EN ISO 9001 and DIN EN 13485. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
RLM.L